Back

MiRNA Locker: A Modularized DNA Assembly As miRNA Inhibitors

Zhu, L.; Min, L.; Zhu, C.-s.; Wu, X.; Li, W.; Ma, J.; Lei, Y.; Gao, C.; Qiu, X.; Liu, C.

2025-01-11 synthetic biology
10.1101/2025.01.10.632138 bioRxiv
Show abstract

MicroRNAs (miRNAs) are vital post-transcriptional regulators that govern key cellular processes such as proliferation, migration, and apoptosis. Current loss-of-function approaches, including chemically modified antisense oligonucleotides (ASOs), face significant challenges, including high costs, limited scalability, and off-target effects. To overcome these limitations, we developed "miRNA Locker", a novel miRNA inhibition platform created using the Overlapped Oligo Assembly (OOA) method. This innovative platform constructs highly stable dumbbell-shaped single-stranded DNA structures, offering improved target specificity, scalability, and cost-effectiveness. Using miR-214 as a proof-of-concept target, we demonstrated that miRNA Lockers effectively bind Argonaute-miRNA complexes, reduce miRNA levels, and induce downstream changes in gene expression and cellular phenotypes, surpassing the performance of commercial antagomirs. Furthermore, applying miRNA Lockers to miR-654 validated the regulatory role of miR-654 in modulating RNF8 expression and promoting epithelial-mesenchymal transition (EMT) in lung cancer cells. Our results highlight the potential of miRNA Lockers as a versatile tool for studying miRNA function and advancing miRNA-based therapies. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=114 SRC="FIGDIR/small/632138v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@c6ac1eorg.highwire.dtl.DTLVardef@14e2698org.highwire.dtl.DTLVardef@1c7d84aorg.highwire.dtl.DTLVardef@148f9c1_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Molecular Therapy Nucleic Acids
39 papers in training set
Top 0.1%
22.3%
2
Molecular Therapy - Nucleic Acids
25 papers in training set
Top 0.1%
15.4%
3
Nucleic Acids Research
1281 papers in training set
Top 2%
8.0%
4
ACS Synthetic Biology
287 papers in training set
Top 0.6%
5.6%
50% of probability mass above
5
ACS Omega
105 papers in training set
Top 0.4%
4.1%
6
Synthetic and Systems Biotechnology
11 papers in training set
Top 0.1%
2.5%
7
Nature Communications
5641 papers in training set
Top 39%
2.5%
8
International Journal of Molecular Sciences
494 papers in training set
Top 5%
2.5%
9
RNA Biology
78 papers in training set
Top 0.5%
2.4%
10
Molecular Therapy
81 papers in training set
Top 0.6%
2.4%
11
Scientific Reports
3612 papers in training set
Top 42%
2.4%
12
PLOS ONE
5266 papers in training set
Top 44%
2.2%
13
ChemBioChem
55 papers in training set
Top 0.5%
1.9%
14
The FASEB Journal
194 papers in training set
Top 2%
1.8%
15
The CRISPR Journal
39 papers in training set
Top 0.3%
1.1%
16
PeerJ
308 papers in training set
Top 8%
1.1%
17
RNA
189 papers in training set
Top 1%
1.1%
18
RSC Chemical Biology
39 papers in training set
Top 0.6%
1.0%
19
eLife
5828 papers in training set
Top 61%
1.0%
20
Angewandte Chemie International Edition
93 papers in training set
Top 2%
0.9%
21
iScience
1154 papers in training set
Top 33%
0.9%
22
Computational and Structural Biotechnology Journal
242 papers in training set
Top 6%
0.9%
23
Theranostics
37 papers in training set
Top 1%
0.6%
24
Genomics, Proteomics & Bioinformatics
172 papers in training set
Top 2%
0.6%
25
Cellular Signalling
14 papers in training set
Top 0.4%
0.6%
26
Cancer Gene Therapy
11 papers in training set
Top 0.2%
0.6%
27
Science China Life Sciences
29 papers in training set
Top 0.7%
0.6%
28
Biomedicine & Pharmacotherapy
42 papers in training set
Top 2%
0.6%